Ageing, ACE2 deficiency and bad outcome in COVID-19

被引：16
|
作者：
Angeli, Fabio [5 ,6 ]
Reboldi, Gianpaolo [1 ,2 ]
Verdecchia, Paolo [3 ,4 ]
机构：
[1] Univ Perugia, Dept Med, Perugia, Italy
[2] Univ Perugia, Ctr Ric Clin & Traslazionale CERICLET, Perugia, Italy
[3] Hosp S Maria Misericordia, Fdn Umbra Cuore & Ipertensione ONLUS, Perugia, Italy
[4] Hosp S Maria Misericordia, Div Cardiol, Perugia, Italy
[5] Univ Insubria, Dept Med & Surg, Varese, Italy
[6] IRCCS Tradate, Maugeri Care & Res Inst, Dept Med & Cardiopulm Rehabil, Tradate, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2021年 / 59卷 / 10期
关键词：
D O I：
10.1515/cclm-2021-0658
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1607 / 1609
页数：3
相关论文
共 50 条
  • [1] ACE2 polymorphisms as potential players in COVID-19 outcome
    Khayat, Andre Salim
    de Assumpcao, Paulo Pimentel
    Meireles Khayat, Bruna Claudia
    Thomaz Araujo, Taissa Maira
    Batista-Gomes, Jessica Almeida
    Imbiriba, Luciana Carvalho
    Ishak, Geraldo
    de Assumpcao, Paula Barauna
    Moreira, Fabiano Cordeiro
    Burbano, Rommel Rodriguez
    Ribeiro-dos-Santos, Andre
    Ribeiro-dos-Santos, Andrea Kelly
    dos Santos, Ney Pereira Carneiro
    dos Santos, Sidney Emmanuel Batista
    PLOS ONE, 2020, 15 (12):
  • [2] Covid-19, ACE2 and the kidney
    Hardenberg, Jan-Hendrik B.
    Luft, Friedrich C.
    ACTA PHYSIOLOGICA, 2020, 230 (01)
  • [3] ACE2, Metformin, and COVID-19
    Malhotra, Atul
    Hepokoski, Mark
    McCowen, Karen C.
    Shyy, John Y-J
    ISCIENCE, 2020, 23 (09)
  • [4] Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
    Kragstrup, Tue W.
    Singh, Helene Sogaard
    Grundberg, Ida
    Nielsen, Ane Langkilde-Lauesen
    Rivellese, Felice
    Mehta, Arnav
    Goldberg, Marcia B.
    Filbin, Michael R.
    Qvist, Per
    Bibby, Bo Martin
    PLOS ONE, 2021, 16 (06):
  • [5] ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19
    Maza, Maria del Carmen
    Ubeda, Maria
    Delgado, Pilar
    Horndler, Lydia
    Llamas, Miguel A.
    van Santen, Hisse M.
    Alarcon, Balbino
    Abia, David
    Garcia-Bermejo, Laura
    Serrano-Villar, Sergio
    Bastolla, Ugo
    Fresno, Manuel
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease
    Gan, Rosemary
    Rosoman, Nicholas P.
    Henshaw, David J. E.
    Noble, Euan P.
    Georgius, Peter
    Sommerfeld, Nigel
    MEDICAL HYPOTHESES, 2020, 144
  • [7] Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19
    Joshua R. Cook
    John Ausiello
    Reviews in Endocrine and Metabolic Disorders, 2022, 23 : 151 - 170
  • [8] Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19
    Cook, Joshua R.
    Ausiello, John
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (02): : 151 - 170
  • [9] COVID-19: is the ACE2 just a foe?
    Jakovac, Hrvoje
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 318 (05) : L1025 - L1026
  • [10] COVID-19, ACE2, and the cardiovascular consequences
    South, Andrew M.
    Diz, Debra, I
    Chappell, Mark C.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 318 (05): : H1084 - H1090
12345